Board of Scientific Counselors, National Center for Health Statistics (BSC, NCHS); Correction, 65674-65675 [2018-27718]

Download as PDF 65674 Federal Register / Vol. 83, No. 245 / Friday, December 21, 2018 / Notices ACTION: Change in Bank Control Notices; Acquisitions of Shares of a Bank or Bank Holding Company SUMMARY: The notificants listed below have applied under the Change in Bank Control Act (12 U.S.C. 1817(j)) and § 225.41 of the Board’s Regulation Y (12 CFR 225.41) to acquire shares of a bank or bank holding company. The factors that are considered in acting on the notices are set forth in paragraph 7 of the Act (12 U.S.C. 1817(j)(7)). The notices are available for immediate inspection at the Federal Reserve Bank indicated. The notices also will be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing to the Reserve Bank indicated for that notice or to the offices of the Board of Governors. Comments must be received not later than January 8, 2019. A. Federal Reserve Bank of Chicago (Colette A. Fried, Assistant Vice President) 230 South LaSalle Street, Chicago, Illinois 60690–1414: 1. Gary F. Stewart and Carrie L. Irish, as a group acting in concert to be added to the Hodgson family control group approved on October 10, 2013; to retain voting shares of Charlevoix First Corporation and thereby indirectly retain shares of Charlevoix State Bank, both of Charlevoix, Michigan. B. Federal Reserve Bank of Kansas City (Dennis Denney, Assistant Vice President) 1 Memorial Drive, Kansas City, Missouri 64198–0001: 1. The Lisa K. Haines Financial Services Trust and the Julee S. Thummel Financial Services Trust, both of Horseshoe Bay, Texas; to retain voting shares of Bank7 Corp and thereby indirectly retain shares of Bank 7, both of Oklahoma City, Oklahoma. Board of Governors of the Federal Reserve System, December 18, 2018. Yao-Chin Chao, Assistant Secretary of the Board. [FR Doc. 2018–27667 Filed 12–20–18; 8:45 am] BILLING CODE P DEPARTMENT OF HEALTH AND HUMAN SERVICES amozie on DSK3GDR082PROD with NOTICES1 Notice of meeting. FEDERAL RESERVE SYSTEM Centers for Disease Control and Prevention Board of Scientific Counselors, National Center for Health Statistics (BSC, NCHS) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). AGENCY: VerDate Sep<11>2014 00:00 Dec 21, 2018 Jkt 247001 In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC), announces the following meeting for the Board of Scientific Counselors, National Center for Health Statistics (BSC, NCHS). This meeting is open to the public. DATES: The meeting will be held on January 22, 2019, 11:00 a.m. to 2:00 p.m., EDT. ADDRESSES: Virtual—Summaries of meetings and a roster of Committee members are available on the NCHS BSC website: https://www.cdc.gov/nchs/ about/bsc.htm. FOR FURTHER INFORMATION CONTACT: Sayeedha Uddin, M.D., M.P.H., Executive Secretary, NCHS/CDC, Board of Scientific Counselors, 3311 Toledo Road, Room 2627, Hyattsville, Maryland 20782, telephone (301) 458–4303, email isx9@cdc.gov. SUPPLEMENTARY INFORMATION: To join the session go to https://roseliassociates. webex.com/roseliassociates/k2/j.php? MTID=tfdddad42079860e7fedf3935962 fd22f. 2. Enter your name and email address (or registration ID). 3. Enter the session password: Jan22. 4. Click ‘‘Join Now’’. 5. Follow the instructions that appear on your screen. To join the session by phone only call the number below and enter the access code. United States Toll Free: 1–844–621– 3956. United States Toll (San Jose): +1–240– 454–0887. Global call-in numbers: https:// roseliassociates.webex.com/ roseliassociates/globalcallin. php?serviceType=TC&ED=753000 972&tollFree=1. Show toll-free dialing restrictions: https://www.webex.com/pdf/tollfree_ restrictions.pdf. Access code: 647 874 925. For assistance you can contact Michele Dillon at: michele.dillon@ roseliassociates.com, 1–301–412–0987. Can’t join the training session? https://collaborationhelp.cisco.com/ article/qg8vzfb. To update this session to your calendar program (for example Microsoft Outlook), click this link: https://roseliassociates.webex.com/ roseliassociates/k2/j.php? MTID=t1946c9546eabdef918f44 ebc6b656537. https://www.webex.com. Purpose: This committee is charged with providing advice and making PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 recommendations to the Secretary, Department of Health and Human Services; the Director, CDC; and the Director, NCHS, regarding the scientific and technical program goals and objectives, strategies, and priorities of NCHS. Matters to be considered: The agenda will include remarks by NCHS leadership; presentation and discussion of the Patient-Centered Outcomes Research Trust Fund Drug Workgroup report. Agenda items are subject to change as priorities dictate. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2018–27719 Filed 12–20–18; 8:45 am] BILLING CODE 4163–19–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Board of Scientific Counselors, National Center for Health Statistics (BSC, NCHS); Correction Notice is hereby given of a change in the meeting of the Board of Scientific Counselors, National Center for Health Statistics (BSC, NCHS); December 4, 2018, 11:00 a.m.–5:30 p.m., EDT, and December 5, 2018, 8:30 a.m.–1:00 p.m., EDT which was published in the Federal Register on November 16, 2017 Volume 82, Number 220, pages 53500– 53501. The date should read as follows: December 4, 2018 10:00 a.m.–5:00 p.m. EST. The MATTERS TO BE CONSIDERED should read as follows: The meeting agenda includes welcome remarks by NCHS leadership; an update on the National Health Interview Statistics Redesign Bridge Sample; an update on the Utilization of Electronic Health Records (EHR) Data in NCHS Data Systems update on National Study of Long-Term Care Providers; an update from the Patient-Centered Outcomes Research Trust Fund Drug Workgroup; an update on Indicator Selection for Healthy People 2030; and an update on Evaluation of Birth Outcomes Associated with Drug Use. E:\FR\FM\21DEN1.SGM 21DEN1 Federal Register / Vol. 83, No. 245 / Friday, December 21, 2018 / Notices FOR FURTHER INFORMATION CONTACT: Sayeedha Uddin, M.D., M.P.H., Executive Secretary, NCHS/CDC, Board of Scientific Counselors, 3311 Toledo Road, Room 2627, Hyattsville, Maryland 20782, telephone (301) 458–4303, email isx9@cdc.gov. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Sherri Berger Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2018–27718 Filed 12–20–18; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHACHSPT); Notice of Charter Renewal Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). AGENCY: ACTION: Notice of charter renewal. This gives notice under the Federal Advisory Committee Act of October 6, 1972, that the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHACHSPT), Centers for Disease Control and Prevention, Department of Health and Human Services, has been renewed for a 2-year period through November 25, 2020. SUMMARY: amozie on DSK3GDR082PROD with NOTICES1 FOR FURTHER INFORMATION CONTACT: Jonathan Mermin, M.D., M.P.H., Designated Federal Officer, CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHACHSPT), CDC, HHS, 1600 Clifton Road, NE, Mailstop E07, Atlanta, Georgia 30329–4027, Telephone 404–639–8000, jhm7@ cdc.gov. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and VerDate Sep<11>2014 00:00 Dec 21, 2018 Jkt 247001 65675 Prevention and the Agency for Toxic Substances and Disease Registry. DEPARTMENT OF HEALTH AND HUMAN SERVICES Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. Centers for Disease Control and Prevention [FR Doc. 2018–27717 Filed 12–20–18; 8:45 am] Notice of Closed Meeting BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Notice of Closed Meeting In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting. The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Name of Committee: Safety and Occupational Health Study Section (SOHSS); National Institute for Occupational Safety and Health (NIOSH). Date: February 20–21, 2019. Time: 8:00 a.m.–5:00 p.m., EST. Place: Embassy Suites, 1900 Diagonal Road, Alexandria, VA 22314. Agenda: The meeting will convene to address matters related to the conduct of Study Section business and for the study section to consider safety and occupational health-related grant applications. For Further Information Contact: Nina Turner, Ph.D., Scienitific Review Officer, NIOSH, 1095 Willowdale Road, Morgantown, WV 26506, (304) 285–5976; nturner@cdc.gov. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2018–27721 Filed 12–20–18; 8:45 am] Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—PAR 13–129; NIOSH Member Conflict Special Emphasis Panel. Date: February 26, 2019. Time: 12:00 p.m.–4:00 p.m. EST. Place: Teleconference. Agenda: To review and evaluate grant applications. For Further Information Contact: Nina Turner, Ph.D., Scientific Review Officer, Office of Extramural Programs, 1095 Willowdale Road, Morgantown, West Virginia 26506, Telephone: (304) 285–5976; Email: nxt2@cdc.gov. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2018–27722 Filed 12–20–18; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention CDC/Mine Safety and Health Research Advisory Committee (MSHRAC); Notice of Charter Renewal BILLING CODE 4163–18–P PO 00000 Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended, and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). AGENCY: Frm 00054 Fmt 4703 Sfmt 4703 E:\FR\FM\21DEN1.SGM 21DEN1

Agencies

[Federal Register Volume 83, Number 245 (Friday, December 21, 2018)]
[Notices]
[Pages 65674-65675]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-27718]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Board of Scientific Counselors, National Center for Health 
Statistics (BSC, NCHS); Correction

    Notice is hereby given of a change in the meeting of the Board of 
Scientific Counselors, National Center for Health Statistics (BSC, 
NCHS); December 4, 2018, 11:00 a.m.-5:30 p.m., EDT, and December 5, 
2018, 8:30 a.m.-1:00 p.m., EDT which was published in the Federal 
Register on November 16, 2017 Volume 82, Number 220, pages 53500-53501.
    The date should read as follows: December 4, 2018 10:00 a.m.-5:00 
p.m. EST.
    The MATTERS TO BE CONSIDERED should read as follows: The meeting 
agenda includes welcome remarks by NCHS leadership; an update on the 
National Health Interview Statistics Redesign Bridge Sample; an update 
on the Utilization of Electronic Health Records (EHR) Data in NCHS Data 
Systems update on National Study of Long-Term Care Providers; an update 
from the Patient-Centered Outcomes Research Trust Fund Drug Workgroup; 
an update on Indicator Selection for Healthy People 2030; and an update 
on Evaluation of Birth Outcomes Associated with Drug Use.

[[Page 65675]]


FOR FURTHER INFORMATION CONTACT: Sayeedha Uddin, M.D., M.P.H., 
Executive Secretary, NCHS/CDC, Board of Scientific Counselors, 3311 
Toledo Road, Room 2627, Hyattsville, Maryland 20782, telephone (301) 
458-4303, email isx9@cdc.gov.
    The Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Sherri Berger
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2018-27718 Filed 12-20-18; 8:45 am]
 BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.